Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer. An expert in chip...

Precision Neuroscience Expands Clinical Research In Brain–Computer Interface NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at...

Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced it has acquired a microelectromechanical systems...

Precision Neuroscience Begins First-in-Human Study of its Neural Interface Technology NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Brain–computer interface company Precision Neuroscience Corporation today announced that the first-in-human procedures in a pilot clinical study of its...

Precision Neuroscience Raises $41 Million to Build and Scale the Next Generation of Treatments for Neurological Illnesses NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation, the only brain–computer interface (BCI) company developing implants that are designed to be high-resolution, minimally...